liposomal bupivacaine

Do Patients Desire Liposomal Bupivacaine After Wisdom Teeth Surgery

by

An interesting article titled “Are Patients Interested in Liposomal Bupivacaine as a Nonopioid Alternative for Postsurgical Analgesia Following Third Molar Extractions?” written by Annie Ho and et. al. appears in the Journal of Oral and Maxillofacial Surgery (online August 9, 2023). The article seeks to determine a patient interest in the use of Liposomal Bupivacaine as an alternative to opioids after wisdom teeth extraction. Studies have shown that patients given opioids after surgery have a 44% increased risk of long-term opioid use. Long lasting local anesthetics like liposomal bupivacaine (LB) were first approved in the U.S by the Food and Drug Administration in2011. Only a single dose to the surgical site is needed for postsurgical analgesia. Research has shown that Liposomal Bupivacaine can lower cumulative pain scores, reduce opioid requirements, and make for faster discharges from the hospital. Although Liposomal … Read more

Using Bupivacaine with Wisdom Teeth Removal Results in Less Opioids Prescribed

by

An interesting article titled “A Retrospective Cross-Sectional Study of the Effect of Liposomal Bupivacaine on Postoperative Opioid Prescribing After Third Molar Extraction,” written by Stuart E. Lieblich and et al. appears in the Journal of Oral and Maxillofacial Surgery (vol. 79, pp. 1401-1408, 2021). The study seeks to explore if patients who have lower wisdom teeth removed using liposomal bupivacaine need less opioids than those wo do not have liposomal bupivacaine. In the study the authors performed a retrospective study of patients who had undergone wisdom teeth extraction at 2 outpatient oral surgery centers in the United States. Patients had to have been at least 18 years of age and undergoing an elective wisdom tooth removal with 1 partial bony or full bony lower impacted wisdom tooth. A total of 600 patients who underwent wisdom teeth extracted were included in … Read more